• Title/Summary/Keyword: MG Safety System

Search Result 213, Processing Time 0.031 seconds

Egg Antibody Farming and IgY Technology for Food and Biomedical Applications

  • Sim, J.S.;Sunwoo, H.H.
    • Korean Journal of Poultry Science
    • /
    • v.31 no.1
    • /
    • pp.37-44
    • /
    • 2004
  • It has been recognized that the hen, like its mammalian counterparts, provides young chicks with antibodies as protection against hostile invaders. This system facilitates the transfer of specific antibodies from serum to egg yolk, and provides a supply of antibodies called immunoglobulin Y(IgY) to the developing embryo and the hatched chick. The protection against pathogens that the relatively immune-incompetent newly hatched chick has, is through transmission of antibodies from the mother via the egg. Egg yolk, therefore, can be loaded with a large amount of IgY against pathogens which can immobilize the existing or invading pathogens during the embryo development or in day-old chicks. Thus, the immunization of laying hens to various pathogens results in production of different antigen-specific IgY in eggs. Egg yolk contains 8∼20 mg of jmmunoglobulins (IgY) per ml or 136∼340 mg per yolk suggesting that more than 30 g of IgY can be obtained from one immunized hen in a year. By immunizing laying hens with antigens and collecting IgY from egg yolk, low cost antibodies at less than $10 per g compared to more than $20,000 per g of mammalian IgG can be obtained. This IgY technology opens new potential market applications in medicine, public health, veterinary medicine and food safety. A broader use of IgY technology could be applied as biological or diagnostic tool, nutraceutical or functional food development, oral-supplementation for prophylaxis, and as pathogen-specific antimicrobial agents for infectious disease control. This paper has emphasized that when IgY-loaded chicken eggs are produced and consumed, the specific antibody binds, immobilizes and consequently reduces or inhibits the growth or colony forming abilities of microbial pathogens. This concept could serve as an alternative agent to replace the use of antibiotics, since today, more and more antibiotics are less effective in the treatment of infections, due to the emergence of drug-resistant bacteria.

Split genome-based retroviral replicating vectors achieve efficient gene delivery and therapeutic effect in a human glioblastoma xenograft model

  • Moonkyung, Kang;Ayoung, Song;Jiyoung, Kim;Se Hun, Kang;Sang-Jin, Lee;Yeon-Soo, Kim
    • BMB Reports
    • /
    • v.55 no.12
    • /
    • pp.615-620
    • /
    • 2022
  • The murine leukemia virus-based semi-retroviral replicating vectors (MuLV-based sRRV) had been developed to improve safety and transgene capacity for cancer gene therapy. However, despite the apparent advantages of the sRRV, improvements in the in vivo transduction efficiency are still required to deliver therapeutic genes efficiently for clinical use. In this study, we established a gibbon ape leukemia virus (GaLV) envelope-pseudotyped semi-replication-competent retrovirus vector system (spRRV) which is composed of two transcomplementing replication-defective retroviral vectors termed MuLV-Gag-Pol and GaLV-Env. We found that the spRRV shows considerable improvement in efficiencies of gene transfer and spreading in both human glioblastoma cells and pre-established human glioblastoma mouse model compared with an sRRV system. When treated with ganciclovir after intratumoral injection of each vector system into pre-established U-87 MG glioblastomas, the group of mice injected with spRRV expressing the herpes simplex virus type 1-thymidine kinase (HSV1-tk) gene showed a survival rate of 100% for more than 150 days, but all control groups of mice (HSV1-tk/PBS-treated and GFP/GCV-treated groups) died within 45 days after tumor injection. In conclusion, these findings sug-gest that intratumoral delivery of the HSV1-tk gene by the spRRV system is worthy of development in clinical trials for the treatment of malignant solid tumors.

Residue Dissipation Patterns of Neonicotinoid Acetamiprid and Thiamethoxam in Swiss Chard for the Harvest Periods under Greenhouse Conditions (시설재배 근대 중 Neonicotinoid계 살충제 Acetamiprid 및 Thiamethoxam의 생산단계 잔류특성)

  • Chang, Hee-Ra;You, Jung-Sun;Do, Jung-Ah
    • Korean Journal of Environmental Agriculture
    • /
    • v.37 no.2
    • /
    • pp.97-103
    • /
    • 2018
  • BACKGROUND: Dissipation of acetamiprid and thiamethoxam in greenhouse grown chard samples was evaluated at 5 intervals including the pre-harvest interval after application. This study was conducted to determine the residue levels, the biological half-lives and dissipation rate of acetamiprid and thiamethoxam in chard under controlled conditions. METHODS AND RESULTS: Acetamiprid and thiamethoxam were applied in accordance with good agricultural practices for chard. Chard samples were collected at 0, 1, 2, 3, 5, 7, 10 and 14 days after application. Quantitaion was performed by HPLC-DAD system with C18 column. Limit of quantification (LOQ) of acetamiprid and thiamethoxam were both 0.02 mg/kg for chard. The recovery of acetamiprid and thiamethoxam were 77.8~107.5% and 94.3~108.6% at two concentration levels. The half-lives of pesticide dissipation in chard for two fields were 11.9 and 8.2 days for acetamiprid and 3.6 and 3.3 days for thiamethoxam respectively. The dissipation rate of acetamiprid and thiamethoxam were estimated according to the statistics method with a 95% confidence. CONCLUSION: Dissipation of acetamiprid and thiamethoxam in chard were determined under greenhouse. The concentration of acetamiprid and thiamethoxam in chards at 0 days after application were below specified by Korean MRL. Dissipation rate constant will be useful to set the pre-harvest residue limit for public health and consumer protection.

Estimation of Total Dust Concentration Complying with the TLV of Airborne Man-made Mineral Fibers by Regression Analysis (회귀분석에 의한 공기중 인조광물 섬유 허용기준과 부합하는 총분진 농도의 추정)

  • Shin, Yong Chul;Yi, Gwang Yong
    • Journal of Korean Society of Occupational and Environmental Hygiene
    • /
    • v.9 no.2
    • /
    • pp.158-166
    • /
    • 1999
  • The purpose of this study was to investigate the correlation between airborne total dust and man-made mineral fibers (MMMF), and to estimate total dust concentration to maintain below the American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value (TLV$^{(R)}$) for the MMMF. The regression coefficients between airborne total dust concentrations and fiber concentrations determined in the industries producing glass fibers, rock wool. refractory ceramic and continuous filament glass fibers products were 0.41, 0.42, 0.20 and 0.19, respectively. The size characteristics of fibers as well as the amounts of contaminated non-fibrous dusts could affect the correlation intensities. When total dust and fiber exposure data were compared with the occupational exposure limits, there was a large gap between two evaluation results. The regression coefficient between total dust and fiber data was increased ($r^2=0.88$) in the process of insulation installation generating in the higher levels of glass or rock wool fibers. In this case, an estimated total dust concentration of glass wool or rock wool fibers complying with the ACGIH TLV (1 f/cc) was $1.7mg/m^3$. In conclusion, the total dust and fibers concentrations was highly correlated at the higher exposure levels so that total dust-monitoring data could be used to control simply and economically and to estimate worker's exposure to fibers.

  • PDF

Enhanced Expression and Functional Characterization of the Recombinant Putative Lysozyme-PMAP36 Fusion Protein

  • Rao, Zhili;Kim, So Young;Akanda, Md Rashedunnabi;Lee, Su Jin;Jung, In Duk;Park, Byung-Yong;Kamala-Kannan, Seralathan;Hur, Jin;Park, Jung Hee
    • Molecules and Cells
    • /
    • v.42 no.3
    • /
    • pp.262-269
    • /
    • 2019
  • The porcine myeloid antimicrobial peptide (PMAP), one of the cathelicidin family members, contains small cationic peptides with amphipathic properties. We used a putative lysozyme originated from the bacteriophage P22 (P22 lysozyme) as a fusion partner, which was connected to the N-terminus of the PMAP36 peptide, to markedly increase the expression levels of recombinant PMAP36. The PMAP36-P22 lysozyme fusion protein with high solubility was produced in Escherichia coli. The final purified yield was approximately 1.8 mg/L. The purified PMAP36-P22 lysozyme fusion protein exhibited antimicrobial activity against both Gram-negative and Grampositive bacteria (Staphylococcus aureus, Salmonella enterica serovar Typhimurium, Pseudomonas aeruginosa, and Bacillus subtilis). Furthermore, we estimated its hemolytic activity against pig erythrocytes as 6% at the high concentration ($128{\mu}M$) of the PMAP36-P22 lysozyme fusion protein. Compared with the PMAP36 peptide (12%), our fusion protein exhibited half of the hemolytic activity. Overall, our recombinant PMAP36-P22 lysozyme fusion protein sustained the antimicrobial activity with the lower hemolytic activity associated with the synthetic PMAP36 peptide. This study suggests that the PMAP36-P22 lysozyme fusion system could be a crucial addition to the plethora of novel antimicrobials.

A comparison of analgesic efficacy and safety of clonidine and methylprednisolone as additives to 0.25% ropivacaine in stellate ganglion block for the treatment of complex regional pain syndrome: a prospective randomised single blind study

  • Sreyashi Naskar;Debesh Bhoi;Heena Garg;Maya Dehran;Anjan Trikha;Mohammed Tahir Ansari
    • The Korean Journal of Pain
    • /
    • v.36 no.2
    • /
    • pp.216-229
    • /
    • 2023
  • Background: The role of the sympathetic nervous system appears to be central in causing pain in complex regional pain syndrome (CRPS). The stellate ganglion block (SGB) using additives with local anesthetics is an established treatment modality. However, literature is sparse in support of selective benefits of different additives for SGB. Hence, the authors aimed to compare the efficacy and safety of clonidine with methylprednisolone as additives to ropivacaine in the SGB for treatment of CRPS. Methods: A prospective randomized single blinded study (the investigator blinded to the study groups) was conducted among patients with CRPS-I of the upper limb, aged 18-70 years with American Society of Anaesthesiologists physical status I-III. Clonidine (15 ㎍) and methylprednisolone (40 mg) were compared as additives to 0.25% ropivacaine (5 mL) for SGB. After medical treatment for two weeks, patients in each of the two groups were given seven ultrasound guided SGBs on alternate days. Results: There was no significant difference between the two groups with respect to visual analogue scale score, edema, or overall patient satisfaction. After 1.5 months follow-up, however, the group that received methylprednisolone had better improvement in range of motion. No significant side effects were seen with either drug. Conclusions: The use of additives, both methylprednisolone and clonidine, is safe and effective for the SGB in CRPS. The significantly better improvement in joint mobility with methylprednisolone suggests that it should be considered promising as an additive to local anaesthetics when joint mobility is the concern.

Isoflavone, β-Glucan Content and Antioxidant Activity of Defatted Soybean Powder by Bioconversion with Lentinula edodes (표고 균사에 의한 탈지 대두박 생물전환 발효물의 이소플라본, 베타글루칸 함량 및 항산화활성)

  • Jung, Tae-Dong;Shin, Gi-Hae;Kim, Jae-Min;Choi, Sun-Il;Lee, Jin-Ha;Lee, Sang Jong;Heo, In Young;Park, Seon Ju;Oh, Sea-Kwan;Woo, Koan-Sik;Lim, Jae Kag;Lee, Ok-Hwan
    • Journal of Food Hygiene and Safety
    • /
    • v.31 no.5
    • /
    • pp.386-392
    • /
    • 2016
  • This study investigated the isoflavone content, total phenol content, antioxidant activities (DPPH radical scavenging and oxygen radical absorbance capacity) and ${\beta}$-glucan content of defatted soybean extracts by bioconversion. Soybean was fermented with Lentinula edodes using submerged liquid fermentation system. Defatted soybean powder prepared by hexane (HDS; hexane defatted soybean) and ethanol (EDS; ethanol defatted soybean). The major components of non-fermented HDS (NFHDS) and EDS (NFEDS) were glucoside, such as daidzin, glycitin and genistin. During the bioconversion processing, isoflavone glucoside converted into aglycone such as daidzein, glycitein and genistein. The highest total isoflavone contents of fermented HDS (FHDS) were $2577.96{\mu}g/mL$, and the lowest total isoflavone contents of NFEDS were $428.27{\mu}g/mL$. The highest total phenol contents of fermented EDS (FEDS) was 42.34 mg GAE/g. DPPH radical scavenging and ORAC value were 31.30 to 59.92% and 247.48 to $786.36{\mu}M\;TE/g$ in non-fermented defatted soybean and fermented soybean, respectively. ${\beta}$-Glucan contents were 0.09 to 0.11% in non-fermented defatted soybean and fermented soybean, respectively. These results indicate that fermented soybean could be used as natural antioxidants for the development of functional foods.

Evaluation of Phytochemical Composition and Antioxidant Capacity in Various Leafy Vegetables

  • Lee, Joon-Hee;Lee, Sun-Young;Lee, Hyang-Jung;Kim, Young-Jun;Koh, Kyung-Hee
    • Preventive Nutrition and Food Science
    • /
    • v.14 no.1
    • /
    • pp.43-48
    • /
    • 2009
  • Current study investigated phytochemical compositions and antioxidant capacity of Korean leafy vegetables including chajogi, gomchwi, meowi and sseumbagwi. ${\beta}$-carotene, total soluble polyphenol, total flavonoids contents were determined, and antioxidant capacity were evaluated by various methods. ${\beta}$-carotene, total soluble polyphenol, total flavonoids contents in gomchwi were significantly higher (as much as 19 folds) compare to other vegetables (p<0.05). Sseumbagwi extract ($100{\mu}g/mL$) was removed 78.6% of superoxide radicals in xanthin-xanthin oxidase system measured by EPR. Gomchwi showed the highest nitrate scavenging activity as 94.3% at pH 1.2. In SOD-like activity, chajogi, gomchwi, and meowi were evaluated in the range of $12.6{\sim}24.5%$. All samples were revealed to prevent the reaction of ferrous chloride during 9 days, which were comparable ability with 125 mg/100 g of ${\alpha}$-tocopherol. The rich phytochemical contents of gomchwi and sseumbagwi influenced to high antioxidant capacity.

Surface Modification of Phosphoric Acid-activated Carbon in Spent Coffee Grounds to Enhance Cu(II) Adsorption from Aqueous Solutions

  • Choi, Suk Soon;Choi, Tae Ryeong;Choi, Hee-Jeong
    • Applied Chemistry for Engineering
    • /
    • v.32 no.5
    • /
    • pp.589-598
    • /
    • 2021
  • The purpose of this study was to analyze the efficiency with which phosphorylated spent coffee grounds (PSCG) remove cationic Cu(II) ions from an aqueous solution. The pHpzc of the SCG was 6.43, but it was lowered to 3.96 in the PSCG, confirming that an acidic functional group was attached to the surface of the PSCG. According to FT-IR analysis, phosphorylation of the SCG added P=O, P-O-C (aromatic), P=OOH, and P-O-P groups to the surface of the adsorbent, and the peaks of the carboxyl and OH groups were high and broad. Also, the specific surface area, mesopore range, and ion exchange capacity increased significantly by phosphorylation. The adsorption kinetics and isothermal experiments showed that Cu(II) adsorption using SCG and PSCG was explained by PSO and Langmuir models. The maximum Langmuir adsorption capacity of SCG and PSCG was 42.23 and 162.36 mg/g, respectively. The adsorption process of both SCG and PSCG was close to physical adsorption and endothermic reaction in which the adsorption efficiency increased with temperature. PSCG was very effective in adsorbing Cu(II) in aqueous solution, which has great advantages in terms of recycling resources and adsorbing heavy metals using waste materials.

Resveratrol: Twenty Years of Growth, Development and Controversy

  • Pezzuto, John M.
    • Biomolecules & Therapeutics
    • /
    • v.27 no.1
    • /
    • pp.1-14
    • /
    • 2019
  • Resveratrol was first isolated in 1939 by Takaoka from Veratrum grandiflorum O. Loes. Following this discovery, sporadic descriptive reports appeared in the literature. However, spurred by our seminal paper published nearly 60 years later, resveratrol became a household word and the subject of extensive investigation. Now, in addition to appearing in over 20,000 research papers, resveratrol has inspired monographs, conferences, symposia, patents, chemical derivatives, etc. In addition, dietary supplements are marketed under various tradenames. Once resveratrol was brought to the limelight, early research tended to focus on pharmacological activities related to the cardiovascular system, inflammation, and cancer but, over the years, the horizon greatly expanded. Around 130 human clinical trials have been (or are being) conducted with varying results. This may be due to factors such as disparate doses (ca. 5 to 5,000 mg/day) and variable experimental settings. Further, molecular targets are numerous and a dominant mechanism is elusive or nonexistent. In this context, the compound is overtly promiscuous. Nonetheless, since the safety profile is pristine, and use as a dietary supplement is prevalent, these features are not viewed as detrimental. Given the ongoing history of resveratrol, it is reasonable to advocate for additional development and further clinical investigation. Topical preparations seem especially promising, as do conditions that can respond to anti-inflammatory action and/or direct exposure, such as colon cancer prevention. Although the ultimate fate of resveratrol remains an open question, thus far, the compound has inspired innovative scientific concepts and enhanced public awareness of preventative health care.